The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes

Medical Physics

Volumn 33, Issue 11, 2006, Pages 4044-4055

  Ruggieri, Ruggero ^a,c   Nahum, Alan E ^b  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^c NONE   (Italy)

Author keywords

Acute hypoxia; Chronic hypoxia; Dose boost; Hypofractionation; TCP; Temporal variation; Therapeutic ratio

Indexed keywords

BIOLOGICAL ORGANS; IRRADIATION; NUCLEAR MEDICINE; TRANSMISSION CONTROL PROTOCOL;

ACUTE HYPOXIA; CHRONIC HYPOXIAS; DOSE BOOST; HYPOFRACTIONATION; TEMPORAL VARIATION; THERAPEUTIC RATIOS;

TUMORS;

ARTICLE; CANCER RADIOTHERAPY; CELL HETEROGENEITY; CLONOGENESIS; FRACTIONATION; FREQUENCY ANALYSIS; HYPOXIA; OXYGENATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RISK ASSESSMENT; THEORETICAL MODEL; TUMOR; TUMOR VOLUME;

EID: 33750559373     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2358205     Document Type: Article

References (35)

1. C. Clifton Ling, J. Humm, S. Larson, H. Amols, Z. Fuks, S. Leibel, and J. A. Koutcher, " Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality., " Int. J. Radiat. Oncol., Biol., Phys. 47, 551-560 (2000).
2. K. S. Clifford Chao, W. R. Bosch, S. Mutic, J. S. Lewis, F. Dehdashti, M. A. Mintun, J. F. Dempsey, C. A. Perez, J. A. Purdy, and M. J. Welch, " A novel approach to overcome tumour resistance: Cu-ATSM guided intensity-modulated radiation therapy., " Int. J. Radiat. Oncol., Biol., Phys. 49, 1171-1182 (2001).
3. J. M. Brown, " Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation., " Br. J. Radiol. 52, 650-656 (1979).
4. R. H. Thomlinson and L. H. Gray, " The histological structure of some human lung cancers and the possible implications for radiotherapy., " Br. J. Cancer 9, 539-549 (1955).
5. J. S. Rasey, W. Koh, M. L. Evans, L. M. Peterson, T. K. Lewellen, M. M. Graham, and K. A. Krohn, " Quantifying regional hypoxia in human tumours with positron emission tomography of [F18] fluoromisonidazole: A pretherapy study of 37 patients., " Int. J. Radiat. Oncol., Biol., Phys. 36, 417-428 (1996).
6. B. Gallez, C. Baudelet, and B. F. Jordan, " Assessment of tumour oxygenation by electron paramagnetic resonance: principles and applications., " NMR Biomed. 17, 240-262 (2004).
7. *- weighted gradient-echo imaging: a marker of tumour acute hypoxia? " Phys. Med. Biol. 49, 3389-3411 (2004).
8. J. P. Kirkpatrick, L. I. Cárdenas-Navia, and M. W. Dewhirst, " Predicting the effect of temporal variations in pO2 on tumour radiosensitivity., " Int. J. Radiat. Oncol., Biol., Phys. 59, 822-833 (2004).
9. R. A. Popple, R. Ove, and S. Shen, " Tumour control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation., " Int. J. Radiat. Oncol., Biol., Phys. 54, 921-927 (2002).
10. D. Vordermark, D. R. Menke, and J. M. Brown, " Similar radiation sensitivities of acutely and chronically hypoxic cells in HT 1080 fibrosarcoma xenografts., " Radiat. Res. 159, 94-101 (2003).
11. F. Zölzer and C. Streffer, " Increased radiosensitivity with chronic hypoxia in four human tumour cell lines., " Int. J. Radiat. Oncol., Biol., Phys. 54, 910-920 (2002).
12. J. Denekamp and A. Daşu, " Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift., " Acta Oncol. 38, 903-918 (1999).
13. R. Ruggieri, " Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia., " Phys. Med. Biol. 49, 4811-4823 (2004).
14. M. Metha, R. Scrimger, R. Mackie, B. Paliwal, R. Chappell, and J. Fowler, " A new approach to dose escalation in non-small-cell lung cancer., " Int. J. Radiat. Oncol., Biol., Phys. 49, 23-33 (2001).
15. S. Webb and A. E. Nahum, " A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density., " Phys. Med. Biol. 38, 653-666 (1993).
16. A. E. Nahum, B. Movsas, E. M. Horwitz, C. C. Stobbe, and J. D. Chapman, " Incorporating clinical measurements of hypoxia into tumour local control modeling of prostate cancer: implications for the αΒ ratio., " Int. J. Radiat. Oncol., Biol., Phys. 57, 391-401 (2003).
17. E. J. Hall, Radiobiology for the Radiologist, 5th ed. (Lippincott Williams & Wilkins, Philadelphia, 2000), pp. 91-111.
18. M. W. Dewhirst, R. D. Braun, and J. L. Lanzen, " Temporal changes in pO2 of R3230AC tumours in Fischer-344 rats., " Int. J. Radiat. Oncol., Biol., Phys. 42, 723-726 (1998).
19. K. G. Brurberg, B. A. Graff, D. R. Olsen, and E. K. Rofstad, " Tumour line specific pO2 fluctuations in human melanoma xenografts rats., " Int. J. Radiat. Oncol., Biol., Phys. 58, 403-409 (2004).
20. H. L. Janssen, A. S. Ljungkvist, P. F. Rijken, D. Sprong, J. Bussink, A. J. van der Kogel, K. M. Haustermans, and A. C. Begg, " Thymidine analogues to assess microperfusion in human tumors., " Int. J. Radiat. Oncol., Biol., Phys. 62, 1169-1175 (2005).
21. H. L. K. Janssen, K. M. G. Haustermans, D. Sprong, G. Blommestijn, I. Hofland, F. J. Hoebers, E. Blijweert, J. A. Raleigh, G. L. Semenza, M. A. Varia, A. J. Balm, M. F. van Velthuysen, P. Delaere, R. Sciot, and A. C. Begg, " HIF-1A, Pimonidazole, and Iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumours., " Int. J. Radiat. Oncol., Biol., Phys. 54, 1537-1549 (2002).
22. K. G. Brurberg, H. K. Skogmo, B. A. Graff, D. R. Olsen, and E. K. Rofstad, " Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy., " Radiother. Oncol. 77, 220-226 (2005).
23. K. H. Pigott, S. A. Hill, D. J. Chaplin, and M. I. Saunders, " Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry., " Radiother. Oncol. 40, 45-50 (1996).
24. M. K. Martel, R. K. Ten Haken, M. B. Hazuka, M. L. Kessler, M. Strawderman, A. T. Turrisi, T. S. Lawrence, B. A. Frass, and A. S. Lichter, " Estimation of tumour control probability model parameters from 3-D dose distribution of non-small cell lung cancer patients., " Lung Cancer 24, 31-37 (1999).
25. A. S. E. Ljungkvist, J. Bussink, P. F. J. W. Rijken, J. H. A. M. Kaanders, A. J. van der Kogel, and J. Denekamp, " Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas., " Int. J. Radiat. Oncol., Biol., Phys. 54, 215-228 (2002).
26. W. A. Toḿ and J. F. Fowler, " Selective boosting of tumour subvolumes., " Int. J. Radiat. Oncol., Biol., Phys. 48, 593-599 (2000).
27. S. L. S. Kwa, J. V. Lebesque, J. C. M. Theuws, L. B. Marks, M. T. Munley, G. Bentel, D. Oetzel, U. Spahn, M. V. Graham, R. E. Drzymala, J. A. Purdy, A. S. Lichter, M. K. Martel, and R. K. Ten Haken, " Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients., " Int. J. Radiat. Oncol., Biol., Phys. 42, 1-9 (1998).
28. A. E. Nahum, R. Polico, M. Iori, C. Iotti, M. Paiusco, and J. D. Chapman, " Adapting the LQ expression for surviving fraction to organ-at-risk dose distributions: Why large fractions may take sense for 'parallel' OARs., " Radiother. Oncol. 68, S113 [#324] (2003).
29. B. G. Wouters and J. M. Brown, " Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy., " Radiat. Res. 147, 541-550 (1997).
30. L. M. Van Putten and R. F. Kallman, " Oxygenation status of a transplantable tumour during fractionated radiation therapy., " J. Natl. Cancer Inst. (1940-1978) 40, 441-451 (1968).
31. F. Zywietz, W. Reeker, and E. Kochs, " Tumour oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation., " Int. J. Radiat. Oncol., Biol., Phys. 32, 1391-1400 (1995).
32. S. Pinel, M. Barberi-Heyob, E. Cohen-Jonathan, J. Merlin, C. Delmas, F. Plenat, and P. Chastagner, " Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts., " Int. J. Radiat. Oncol., Biol., Phys. 59, 250-259 (2004).
33. H. Lyng, K. Sundfør, and E. K. Rofstad, " Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis., " Int. J. Radiat. Oncol., Biol., Phys. 46, 935-946 (2000).
34. M. Baumann, S. Appold, J. Zimmer, M. Scharf, B. Beuthien-Baumann, H. Dubben, W. Enghardt, A. Schreiber, W. Eicheler, and C. Petersen, " Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy., " Acta Oncol. 40, 519-528 (2001).
35. A. Speke and R. P. Hill, " The effects of clumping and reoxygenation on repopulation during fractionated irradiation., " Int. J. Radiat. Oncol., Biol., Phys. 31, 857-863 (1995).